PROSPECT: A randomized phase III trial of neoadjuvant ...
Jun 7, 2023 · The PROSPECTtrial compares FOLFOX chemotherapy with selective use of 5FUCRT (intervention) to 5FUCRT (control) for neoadjuvant treatment prior to TME for LARC.
Searching…
Jun 7, 2023 · The PROSPECTtrial compares FOLFOX chemotherapy with selective use of 5FUCRT (intervention) to 5FUCRT (control) for neoadjuvant treatment prior to TME for LARC.
Jan 20, 2011 · The Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) study was conducted at 37 sites in the United States and Europe.
Jun 8, 2023 · ASCO每日速递特别在会前就PROSPECT研究采访了该研究报告者Deb Schrag 博士。 她表示:PROSPECT研究最大的收获就是对于部分局部晚期直肠癌患者或可豁免放疗,临床意义很大。
In the PROSPECT study, a large plaque burden, small lumen area and VH-TCFA assessed by intravascular ultrasound (IVUS) identified angiographically mild lesions at increased risk to cause future adverse events
Dec 2, 2015 · PROSPECT II: Multicenter, prospective, natural history study of troponin positive patients with acute coronary syndromes (ACS) examined with angiography and intended for PCI for the initial culprit lesion (s).
Jun 29, 2025 · PROSPECT研究是第一项使用IVUS和VH-IVUS确定易损斑块特征及其与未来冠状动脉事件关联的大型前瞻性研究[5]。 共有697名ACS患者在成功进行罪犯病变经皮冠状动脉介入治疗(PCI)后接受了3支血管血管造影以及IVUS和VH-IVUS评估,以确定非冠状动脉病变。
Mar 21, 2012 · PROSPECT研究是第一项应用冠脉造影及IVUS评估易损斑块自然进程的前瞻性、多中心的研究。 易损斑块诊断标准和技术的敏感性、特异性和预测准确性仍有待于前瞻性的大型临床研究加以明确。